Literature DB >> 10787425

Human ERK1 induces filamentous growth and cell wall remodeling pathways in Saccharomyces cerevisiae.

J M Atienza1, M Suh, I Xenarios, R Landgraf, J Colicelli.   

Abstract

Expression of an activated extracellular signal-regulated kinase 1 (ERK1) construct in yeast cells was used to examine the conservation of function among mitogen-activated protein (MAP) kinases. Sequence alignment of the human MAP kinase ERK1 with all Saccharomyces cerevisiae kinases reveals a particularly strong kinship with Kss1p (invasive growth promoting MAP kinase), Fus3p (pheromone response MAP/ERK kinase), and Mpk1p (cell wall remodeling MAP kinase). A fusion protein of constitutively active human MAP/ERK kinase 1 (MEK) and human ERK1 was introduced under regulated expression into yeast cells. The fusion protein (MEK/ERK) induced a filamentation response element promoter and led to a growth retardation effect concomitant with a morphological change resulting in elongated cells, bipolar budding, and multicell chains. Induction of filamentous growth was also observed for diploid cells following MEK/ERK expression in liquid culture. Neither haploids nor diploids, however, showed marked penetration of agar medium. These effects could be triggered by either moderate MEK/ERK expression at 37 degrees C or by high level MEK/ERK expression at 30 degrees C. The combination of high level MEK/ERK expression and 37 degrees C resulted in cell death. The deleterious effects of MEK/ERK expression and high temperature were significantly mitigated by 1 m sorbitol, which also enhanced the filamentous phenotype. MEK/ERK was able to constitutively activate a cell wall maintenance reporter gene, suggesting misregulation of this pathway. In contrast, MEK/ERK effectively blocked expression from a pheromone-responsive element promoter and inhibited mating. These results are consistent with MEK/ERK promoting filamentous growth and altering the cell wall through its ability to partially mimic Kss1p and stimulate a pathway normally controlled by Mpk1p, while appearing to inhibit the normal functioning of the structurally related yeast MAP kinase Fus3p.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10787425     DOI: 10.1074/jbc.M910024199

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  A conserved docking site in MEKs mediates high-affinity binding to MAP kinases and cooperates with a scaffold protein to enhance signal transmission.

Authors:  A J Bardwell; L J Flatauer; K Matsukuma; J Thorner; L Bardwell
Journal:  J Biol Chem       Date:  2000-12-28       Impact factor: 5.157

2.  Hypotonic swelling-induced activation of PKN1 mediates cell survival in cardiac myocytes.

Authors:  Katsuya Kajimoto; Dan Shao; Hiromitsu Takagi; Gregorio Maceri; Daniela Zablocki; Hideyuki Mukai; Yoshitaka Ono; Junichi Sadoshima
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-10-29       Impact factor: 4.733

3.  Expressed in the yeast Saccharomyces cerevisiae, human ERK5 is a client of the Hsp90 chaperone that complements loss of the Slt2p (Mpk1p) cell integrity stress-activated protein kinase.

Authors:  Andrew W Truman; Stefan H Millson; James M Nuttall; Victoria King; Mehdi Mollapour; Chrisostomos Prodromou; Laurence H Pearl; Peter W Piper
Journal:  Eukaryot Cell       Date:  2006-09-01

4.  Tunable signal processing in synthetic MAP kinase cascades.

Authors:  Ellen C O'Shaughnessy; Santhosh Palani; James J Collins; Casim A Sarkar
Journal:  Cell       Date:  2011-01-07       Impact factor: 41.582

5.  Role of a mitogen-activated protein kinase pathway during conidial germination and hyphal fusion in Neurospora crassa.

Authors:  Amita Pandey; M Gabriela Roca; Nick D Read; N Louise Glass
Journal:  Eukaryot Cell       Date:  2004-04

Review 6.  Integrins in disguise - mechanosensors in Saccharomyces cerevisiae as functional integrin analogues.

Authors:  Tarek Elhasi; Anders Blomberg
Journal:  Microb Cell       Date:  2019-07-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.